Carpenter Technology Corporation logo

Carpenter Technology Corporation (XTY)

Market Open
30 May, 20:00
XBER XBER
206. 00
0
0%
- Market Cap
- P/E Ratio
0.8% Div Yield
0 Volume
- Eps
206
Previous Close
Day Range
204 206
Year Range
89.5 212
Earnings results expected in 50 days

Summary

XTY trading today higher at €206, an increase of 0% from yesterday's close, completing a monthly increase of 13.81% or €25. Over the past 12 months, XTY stock gained 25.61%.
XTY pays dividends to its shareholders, with the most recent payment made on Mar 06, 2025. The next announced payment will be in In 2 days on Jun 05, 2025 for a total of €0.2.
The last earnings report, released on Apr 29, 2025, exceeded the consensus estimates by 0%. On average, the company has fell short of earnings expectations by -0.48%, based on the last three reports. The next scheduled earnings report is due on Jul 23, 2025.
The stock of the company had never split.
The company's stock is traded on 6 different exchanges and in various currencies, with the primary listing on NYSE (USD).
Want to track XTY and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

XTY Chart

Chart

Empty chart
The chart has 2 Y axes displaying values, and values.
Loading, please wait...
End of interactive chart.
Lyra Therapeutics Reports Positive Results from the ENLIGHTEN 2 Phase 3 Trial of LYR-210 Achieving Statistically Significant Results for Primary and Key Secondary Endpoints in the Treatment of Chronic Rhinosinusitis (CRS)

Lyra Therapeutics Reports Positive Results from the ENLIGHTEN 2 Phase 3 Trial of LYR-210 Achieving Statistically Significant Results for Primary and Key Secondary Endpoints in the Treatment of Chronic Rhinosinusitis (CRS)

WATERTOWN, Mass., June 02, 2025 (GLOBE NEWSWIRE) -- Lyra Therapeutics, Inc. (Nasdaq: LYRA) (“Lyra” or the “Company”), a clinical-stage biotechnology company developing long-acting, anti-inflammatory sinonasal implants for the treatment of chronic rhinosinusitis (CRS), today announced positive results from the ENLIGHTEN 2 Phase 3 clinical trial of LYR-210 in adult patients with CRS. The ENLIGHTEN 2 trial met its primary endpoint, with LYR-210 demonstrating statistically significant improvement compared to sham control in a composite of the three cardinal symptoms (3CS) of CRS (nasal obstruction, nasal discharge, facial pain/pressure) at week 24 (-1.13; p=0.0078) in patients without nasal polyps.

Globenewswire | 23 hours ago
Is Carpenter Technology (CRS) Stock Outpacing Its Basic Materials Peers This Year?

Is Carpenter Technology (CRS) Stock Outpacing Its Basic Materials Peers This Year?

Here is how Carpenter Technology (CRS) and Aris Mining Corporation (ARMN) have performed compared to their sector so far this year.

Zacks | 2 weeks ago
Lyra Therapeutics Reports First Quarter 2025 Financial Results and Provides Corporate Update

Lyra Therapeutics Reports First Quarter 2025 Financial Results and Provides Corporate Update

– Phase 3 results from ENLIGHTEN 2 pivotal Phase 3 trial of LYR 210 in Chronic Rhinosinusitis (CRS) expected in Q2 2025 – – Phase 3 results from ENLIGHTEN 2 pivotal Phase 3 trial of LYR 210 in Chronic Rhinosinusitis (CRS) expected in Q2 2025 –

Globenewswire | 3 weeks ago

Carpenter Technology Corporation Dividends

Carpenter Technology Corporation logo
CRS 1 month ago
Announced
Quarterly
$0.2 Per Share
Carpenter Technology Corporation logo
CRS 4 months ago
Paid
Quarterly
$0.2 Per Share
Carpenter Technology Corporation logo
CRS 7 months ago
Paid
Quarterly
$0.2 Per Share
Carpenter Technology Corporation logo
CRS 9 months ago
Paid
Quarterly
$0.2 Per Share
Carpenter Technology Corporation logo
CRS 22 Apr 2024
Paid
Quarterly
$0.2 Per Share

Carpenter Technology Corporation Earnings

23 Jul 2025 (50 Days) Date
-
Cons. EPS
-
EPS
29 Apr 2025 Date
-
Cons. EPS
-
EPS
30 Jan 2025 Date
1.55
Cons. EPS
1.66
EPS
23 Jan 2025 Date
1.55
Cons. EPS
-
EPS
24 Oct 2024 Date
1.58
Cons. EPS
1.73
EPS
Carpenter Technology Corporation logo
CRS 1 month ago
Announced
Quarterly
$0.2 Per Share
Carpenter Technology Corporation logo
CRS 4 months ago
Paid
Quarterly
$0.2 Per Share
Carpenter Technology Corporation logo
CRS 7 months ago
Paid
Quarterly
$0.2 Per Share
Carpenter Technology Corporation logo
CRS 9 months ago
Paid
Quarterly
$0.2 Per Share
Carpenter Technology Corporation logo
CRS 22 Apr 2024
Paid
Quarterly
$0.2 Per Share
23 Jul 2025 (50 Days) Date
-
Cons. EPS
-
EPS
29 Apr 2025 Date
-
Cons. EPS
-
EPS
30 Jan 2025 Date
1.55
Cons. EPS
1.66
EPS
23 Jan 2025 Date
1.55
Cons. EPS
-
EPS
24 Oct 2024 Date
1.58
Cons. EPS
1.73
EPS

Carpenter Technology Corporation (XTY) FAQ

What is the stock price today?

The current price is €206.00.

On which exchange is it traded?

Carpenter Technology Corporation is listed on NYSE.

What is its stock symbol?

The ticker symbol is XTY.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, no market cap data is available.

What is the earnings per share?

The EPS is 0.

When is the next earnings date?

The next earnings report will release on Jul 23, 2025.

Has Carpenter Technology Corporation ever had a stock split?

Carpenter Technology Corporation had 0 splits and the recent split was on Nov 16, 2007.

Carpenter Technology Corporation Profile

Manufacturing - Metal Fabrication Industry
Industrials Sector
Mr. Tony R. Thene CPA CEO
XBER Exchange
US1442851036 ISIN
US Country
4,600 Employees
28 Jan 2025 Last Dividend
16 Nov 2007 Last Split
- IPO Date

Overview

Carpenter Technology Corporation is a leading manufacturer, fabricator, and distributor of specialty metals, serving customers globally across the United States, Europe, the Asia Pacific, Mexico, and Canada. Founded in 1889 and based in Philadelphia, Pennsylvania, Carpenter Technology has built a reputation for innovation and quality in the metals industry. The company operates through two main segments: Specialty Alloys Operations and Performance Engineered Products, catering to a diverse range of markets including aerospace, defense, medical, transportation, energy, industrial, and consumer sectors.

Products and Services

  • Specialty Alloys
  • Includes a wide variety of high-performance materials such as titanium alloys, stainless steels, alloy steels, and tool steels. These alloys are known for their exceptional strength, durability, and resistance to corrosion and heat, making them ideal for critical applications in aerospace, defense, and other technologies.

  • Powder Metals
  • Offers a range of powder metal products designed for high precision, high performance applications. Powder metals are used in manufacturing parts with complex shapes and features, with applications in aerospace, automotive, energy, and medical industries, among others.

  • Additives
  • Carpenter Technology produces various metal-based additive manufacturing powders, designed to enhance the performance and functionality of 3D printed parts. These materials support a broad range of industries, including aerospace, medical, and automotive, by enabling the production of complex geometries that are difficult or impossible to achieve with traditional manufacturing methods.

  • Metal Powders and Parts
  • The company also specializes in the production of metal powders and parts, catering to the specific needs of industries that require high-quality metal components. This includes the production of precision parts for aerospace engines and structures, medical implants, and energy applications, delivering products that meet stringent industry standards.

Contact Information

Address: 1735 Market Street
Phone: 610 208 2000